Minkai Biomedical Joins the "Expert Support for Enterprises · Tour of Yanzhao" Event in Qinhuangdao

Transforming Cancer into a Manageable Chronic Disease: Professor Wang Zhe, CTO of Minkai Biomedical, Explores How Immunomics Is Reshaping the Future of Cancer Therapy

The Innovative Cancer Vaccine and Immunotherapy Research Center of Minkai Biomedical has been officially inaugurated in Lisbon, accelerating China–Europe collaboration and strengthening leadership in the cancer peptide vaccine field